Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on April 14, 2025

Ethiopia to Host the Largest Tech Event in East Africa – Ethiopian Tech Expo (ETEX 2025)
The event, scheduled for May 16-18, 2025, at the Addis International Convention Center, will be organized and managed by QNA. DUBAI, UNITED ARAB EMIRATES, April 14, 2025 /EINPresswire.com/ -- The Information Network Security Administration (INSA) and …

Sterling Commercial Credit Rebrands as Great Elm Commercial Finance
NASHVILLE, Tenn., April 14, 2025 (GLOBE NEWSWIRE) -- Sterling Commercial Credit has rebranded in response to its product expansion, accelerated company growth, and renewal of its corporate vision. At the heart of this rebranding is a change of the company’ …

Lowey Dannenberg Notifies Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) ( …

Lowey Dannenberg Notifies Edison International (“Edison” or the “Company”) (NYSE: EIX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSE: EIX) …

Lowey Dannenberg Notifies Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: RKLB) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: …

Lowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “ …

Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight
New York, USA, April 14, 2025 (GLOBE NEWSWIRE) -- Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near …

Lowey Dannenberg Notifies Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT …

Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “ …

Transaction in Own Shares
Transaction in Own Shares 14 April, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 14 April 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders
HOUSTON, TX, April 14, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is pleased to announce that the United States Patent and …

THEON publishes its FY 2024 Annual Report - Strong financial performance and significant milestones achieved Further strong growth anticipated in FY 2025
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 14 April 2025 – Theon International Plc (THEON) today publishes its FY 2024 Annual Report for the 12 months ended 31 December 2024, with the results demonstrating a very strong performance and …

Georgia DOT Joins States Requiring e-Ticketing for DOT Contractors in 2026, Approves TruckIT as Tech Provider
ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- The Georgia Department of Transportation (GDOT) is ushering in a new era of digital transformation in heavy construction with the launch of a statewide e-Ticketing initiative. Starting in 2026, all contractors …

LOWEY DANNENBERG, P.C. is Investigating Claims on Behalf of California Cryobank LLC Customers Who May Have Been Harmed by a Recent Data Breach
NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. is investigating potential claims regarding a data breach at California Cryobank LLC that occurred between April 20 – 22, 2024. To contact us regarding this investigation, please visit our …

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United …

AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que …

YC-Backed Startup Octolane Raises Seed Round to Challenge Salesforce with the First Self-Driving AI CRM That Automates Sales Actions and Manual CRM Updates
SAN FRANCISCO, April 14, 2025 (GLOBE NEWSWIRE) -- Octolane, which provides the first AI-driven CRM that automates sales actions and CRM updates, announced today an oversubscribed $2.6M seed round. Founded by two young immigrants, Octolane is challenging …

Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse stock split of its outstanding shares of common stock. Cara …

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country
Saint Herblain (France), April 14, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ …

Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique
Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l'autorisation de mise sur le marché à son …